AI Science Tracker

Progeni predicts candidate melanoma and colorectal-cancer targets validated in cell models

Tsinghua University; Westlake University; Jilin University; Silexon AI Technology · 5 Apr 2024 · biology

Discovery

Progeni predicts candidate melanoma and colorectal-cancer targets validated in cell models

Progeni combines a probabilistic knowledge graph with graph neural networks to rank disease-associated molecular targets. The authors selected six candidates lacking literature support and reported that knockdown of HSP90AB1 and MME reduced proliferation in a murine melanoma line, while knockdown of ADCY5, ADRA2A and EEF2 reduced proliferation in a murine colorectal-cancer line.

Technology: Progeni probabilistic knowledge graph and graph neural network

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: The authors selected six candidates lacking literature support and reported that knockdown of HSP90AB1 and MME reduced proliferation in a murine melanoma line, while knockdown of ADCY5, ADRA2A and EEF2 reduced proliferation in a murine colorectal-cancer line.
  • Still unknown: The functional validations were in B16F10 and MC38 murine cell lines, not human tumor samples or clinical settings. The paper evaluates a model and validates selected candidates; it does not establish these as clinically effective therapeutic targets.
  • AI role: The graph neural network ranked new target hypotheses from heterogeneous biological networks and literature co-occurrence evidence. Researchers then tested selected predictions by shRNA knockdown in representative murine cancer cell lines.

Evidence sources: https://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1011945

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 81 of works of the same type, year and subfield (OpenAlex work metrics, 11 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.